Pedex | Boehringer Ingelheim

Purevax Feline 4

Pedex | Boehringer Ingelheim

Purevax Feline 4

DESCRIPTION: PUREVAX® Feline 4 contains a lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci, each propagated in a stable cell line, plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.

INDICATIONS: PUREVAX® Feline 4 is recommended for the vaccination of healthy cats 6 weeks of age and older for prevention of disease due to feline rhinotracheitis, calici, and panleukopenia viruses and as an aid in the reduction of disease due to Chlamydia psittaci.